Aurora Cannabis Ownership
| ACB Stock | USD 4.34 0.02 0.46% |
Shares in Circulation | First Issued 2007-06-30 | Previous Quarter 54.9 M | Current Value 54.9 M | Avarage Shares Outstanding 47 M | Quarterly Volatility 69.2 M |
Aurora |
Aurora Stock Ownership Analysis
About 13.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aurora Cannabis recorded a loss per share of 0.46. The entity last dividend was issued on the 11th of May 2020. The firm had 1:10 split on the 20th of February 2024. Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis is traded on NASDAQ Exchange in the United States. For more info on Aurora Cannabis please contact Michael Singer at 855 279 4652 or go to https://www.auroramj.com.Besides selling stocks to institutional investors, Aurora Cannabis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Aurora Cannabis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Aurora Cannabis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Aurora Cannabis Quarterly Liabilities And Stockholders Equity |
|
Aurora Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aurora Cannabis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aurora Cannabis backward and forwards among themselves. Aurora Cannabis' institutional investor refers to the entity that pools money to purchase Aurora Cannabis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Advisers, Llc | 2024-12-31 | 62.1 K | Td Asset Management Inc | 2024-12-31 | 58.6 K | Cubist Systematic Strategies, Llc | 2024-12-31 | 52 K | Mackenzie Investments | 2024-12-31 | 51 K | Group One Trading, Lp | 2024-12-31 | 41.4 K | Bulltick Wealth Management Llc | 2024-12-31 | 35.4 K | Sontag Advisory Llc | 2024-12-31 | 35 K | Geode Capital Management, Llc | 2024-12-31 | 32.5 K | Centiva Capital Lp | 2024-12-31 | 31.7 K | Tidal Investments Llc. | 2024-12-31 | 1.3 M | Goldman Sachs Group Inc | 2024-12-31 | 714.8 K |
Aurora Cannabis Outstanding Bonds
Aurora Cannabis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aurora Cannabis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aurora bonds can be classified according to their maturity, which is the date when Aurora Cannabis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Aurora Cannabis Corporate Filings
6K | 18th of February 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
| 20th of June 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aurora Cannabis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurora Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurora Cannabis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurora Cannabis Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurora Cannabis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurora Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Earnings Share (0.46) | Revenue Per Share | Quarterly Revenue Growth 0.285 | Return On Assets |
The market value of Aurora Cannabis is measured differently than its book value, which is the value of Aurora that is recorded on the company's balance sheet. Investors also form their own opinion of Aurora Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Aurora Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurora Cannabis' market value can be influenced by many factors that don't directly affect Aurora Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.